These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9342250)

  • 1. Structural aspects of the interaction of peptidyl-glycylleucine-carboxyamide, a highly potent antimicrobial peptide from frog skin, with lipids.
    Latal A; Degovics G; Epand RF; Epand RM; Lohner K
    Eur J Biochem; 1997 Sep; 248(3):938-46. PubMed ID: 9342250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane binding and pore formation of the antibacterial peptide PGLa: thermodynamic and mechanistic aspects.
    Wieprecht T; Apostolov O; Beyermann M; Seelig J
    Biochemistry; 2000 Jan; 39(2):442-52. PubMed ID: 10631006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological activity and structural aspects of PGLa interaction with membrane mimetic systems.
    Lohner K; Prossnigg F
    Biochim Biophys Acta; 2009 Aug; 1788(8):1656-66. PubMed ID: 19481533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid discrimination in phospholipid monolayers by the antimicrobial frog skin peptide PGLa. A synchrotron X-ray grazing incidence and reflectivity study.
    Konovalov O; Myagkov I; Struth B; Lohner K
    Eur Biophys J; 2002 Oct; 31(6):428-37. PubMed ID: 12355252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane thickening by the antimicrobial peptide PGLa.
    Pabst G; Grage SL; Danner-Pongratz S; Jing W; Ulrich AS; Watts A; Lohner K; Hickel A
    Biophys J; 2008 Dec; 95(12):5779-88. PubMed ID: 18835902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of synergism between antimicrobial peptides magainin 2 and PGLa.
    Matsuzaki K; Mitani Y; Akada KY; Murase O; Yoneyama S; Zasloff M; Miyajima K
    Biochemistry; 1998 Oct; 37(43):15144-53. PubMed ID: 9790678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane interaction and perturbation mechanisms induced by two cationic cell penetrating peptides with distinct charge distribution.
    Alves ID; Goasdoué N; Correia I; Aubry S; Galanth C; Sagan S; Lavielle S; Chassaing G
    Biochim Biophys Acta; 2008; 1780(7-8):948-59. PubMed ID: 18498774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raman spectroscopy of synthetic antimicrobial frog peptides magainin 2a and PGLa.
    Williams RW; Starman R; Taylor KM; Gable K; Beeler T; Zasloff M; Covell D
    Biochemistry; 1990 May; 29(18):4490-6. PubMed ID: 2350550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes.
    Wieprecht T; Dathe M; Beyermann M; Krause E; Maloy WL; MacDonald DL; Bienert M
    Biochemistry; 1997 May; 36(20):6124-32. PubMed ID: 9166783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of linear cationic peptides with phospholipid membranes and polymers of sialic acid.
    Kuznetsov AS; Dubovskii PV; Vorontsova OV; Feofanov AV; Efremov RG
    Biochemistry (Mosc); 2014 May; 79(5):459-68. PubMed ID: 24954597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control and role of pH in peptide-lipid interactions in oriented membrane samples.
    Misiewicz J; Afonin S; Ulrich AS
    Biochim Biophys Acta; 2015 Mar; 1848(3):833-41. PubMed ID: 25511586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane thinning caused by magainin 2.
    Ludtke S; He K; Huang H
    Biochemistry; 1995 Dec; 34(51):16764-9. PubMed ID: 8527451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of antimicrobial peptides on the formation of nonlamellar lipid mesophases.
    Hickel A; Danner-Pongratz S; Amenitsch H; Degovics G; Rappolt M; Lohner K; Pabst G
    Biochim Biophys Acta; 2008 Oct; 1778(10):2325-33. PubMed ID: 18582435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential scanning calorimetric study of the effect of the antimicrobial peptide gramicidin S on the thermotropic phase behavior of phosphatidylcholine, phosphatidylethanolamine and phosphatidylglycerol lipid bilayer membranes.
    Prenner EJ; Lewis RN; Kondejewski LH; Hodges RS; McElhaney RN
    Biochim Biophys Acta; 1999 Mar; 1417(2):211-23. PubMed ID: 10082797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of antibacterial action of dermaseptin B2: interplay between helix-hinge-helix structure and membrane curvature strain.
    Galanth C; Abbassi F; Lequin O; Ayala-Sanmartin J; Ladram A; Nicolas P; Amiche M
    Biochemistry; 2009 Jan; 48(2):313-27. PubMed ID: 19113844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of antibacterial magainin peptides to electrically neutral membranes: thermodynamics and structure.
    Wieprecht T; Beyermann M; Seelig J
    Biochemistry; 1999 Aug; 38(32):10377-87. PubMed ID: 10441132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of CAP18-derived peptides with membranes made from endotoxins or phospholipids.
    Gutsmann T; Hagge SO; Larrick JW; Seydel U; Wiese A
    Biophys J; 2001 Jun; 80(6):2935-45. PubMed ID: 11371466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diphytanoyl lipids as model systems for studying membrane-active peptides.
    Kara S; Afonin S; Babii O; Tkachenko AN; Komarov IV; Ulrich AS
    Biochim Biophys Acta Biomembr; 2017 Oct; 1859(10):1828-1837. PubMed ID: 28587828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and orientation of the mammalian antibacterial peptide cecropin P1 within phospholipid membranes.
    Gazit E; Miller IR; Biggin PC; Sansom MS; Shai Y
    J Mol Biol; 1996 May; 258(5):860-70. PubMed ID: 8637016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Position-dependent hydrophobicity of the antimicrobial magainin peptide affects the mode of peptide-lipid interactions and selective toxicity.
    Tachi T; Epand RF; Epand RM; Matsuzaki K
    Biochemistry; 2002 Aug; 41(34):10723-31. PubMed ID: 12186559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.